Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   HTML views PDF downloads Totals
13,392 Dovepress* 12,618+ 1,404 14,022
PubMed Central* 774 245 1,019
Totals 13,392 1,649 15,041
*Since 24 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar